Robert Orlowski, Deputy Chair of Lymphoma/Myeloma, Vice Chair of MM Research, and Florence Maude Thomas Cancer Research Professor at the University of Texas MD Anderson Cancer Center, shared a post on X:
“Myeloma Paper of the Day:
Predictors of deep renal response (>60% proteinuria reduction or ≤200 mg) in AL amyloidosis post-anti-plasma cell tx include obtaining ≥HemVGPR in 6 mos, kappa isotype, dFLC ≥40 mg/dL, renal stage and undergoing ASCT.”
Title: Predictors of renal response in AL amyloidosis following anti-plasma cell therapy: The impact of baseline serum free light chain levels and light chain isotype
Authors: Matthew J. Rees, Binoy Yohannan, Susan Geyer, Suheil Albert Atallah-Yunes, Nadia Toumeh, Morie Gertz, Angela Dispenzieri, Nelson Leung, Suzanne Hayman, Francis Buadi, Joselle Cook, David Dingli, Rahma Warsame, Prashant Kapoor, Moritz Binder, Taxiarchis Kourelis, Wilson Gonsalves, S. Vincent Rajkumar, Shaji Kumar, Eli Muchtar
You can read the Full Article in British Journal of Haematology.
You can find other articles featuring Robert Orlowski on OncoDaily.
